Skip to main content

Research Repository

Advanced Search

Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service

Radford, Shellie J.; Abdul-Aema, Buraq; Tench, Chris; Leighton, Paul; Coad, Jane; Moran, Gordon W.

Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service Thumbnail


Authors

Buraq Abdul-Aema

PAUL LEIGHTON PAUL.LEIGHTON@NOTTINGHAM.AC.UK
Associate Professor of Applied Health Services Research

JANE COAD Jane.Coad@nottingham.ac.uk
Professor of Children and Family Nursing

GORDON MORAN GORDON.MORAN@NOTTINGHAM.AC.UK
Professor of Gastroenterology



Abstract

Background: Imaging is used to monitor disease activity in small bowel Crohn’s disease (CD). Magnetic Resonance Enterography is often employed as a first modality in the United Kingdom for assessment and monitoring; however, waiting times, cost, patient burden and limited access are significant. It is as yet uncertain if small bowel intestinal ultrasound (IUS) may be a quicker, more acceptable, and cheaper alternative for monitoring patients with CD. Methods: A clinical service evaluation of imaging pathways was undertaken at a single NHS site in England, United Kingdom. Data were collected about patients who were referred and underwent an imaging analysis for their IBD. Only patients who underwent a therapy change were included in the analysis. Data were collected from care episodes between 01 January 2021–30 March 2022. Results: A combined total of 193 patient care episodes were reviewed, 107 from the IUS pathway and 86 from the MRE pathway. Estimated costs per patient in the IUS pathway was £78.86, and £375.35 per patient in the MRE pathway. The MRE pathway had an average time from referral to treatment initiation of 91 days (SD= ±61) with patients in the IUS pathway waiting an average of 46 days (SD= ±17). Conclusions: Findings from this work indicate that IUS is a potential cost-saving option when compared to MRE when used in the management of CD. This is in addition to the cost difference of the radiological modalities. A large, multicentre, prospective study is needed to validate these initial findings.

Citation

Radford, S. J., Abdul-Aema, B., Tench, C., Leighton, P., Coad, J., & Moran, G. W. (2024). Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service. Scandinavian Journal of Gastroenterology, 59(6), 683-689. https://doi.org/10.1080/00365521.2024.2330588

Journal Article Type Article
Acceptance Date Mar 8, 2024
Online Publication Date Mar 19, 2024
Publication Date 2024
Deposit Date Mar 8, 2024
Publicly Available Date Mar 20, 2025
Journal Scandinavian Journal of Gastroenterology
Print ISSN 0036-5521
Electronic ISSN 1502-7708
Publisher Taylor and Francis
Peer Reviewed Peer Reviewed
Volume 59
Issue 6
Pages 683-689
DOI https://doi.org/10.1080/00365521.2024.2330588
Keywords Crohn’s disease; IBD; ultrasound; cost implications
Public URL https://nottingham-repository.worktribe.com/output/32176919
Publisher URL https://www.tandfonline.com/doi/full/10.1080/00365521.2024.2330588

Files





You might also like



Downloadable Citations